Richard E. Champlin
Impact in
- Hematology top 0.01%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 0.02%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 751
- Hematopoietic Stem Cell Transplantation 468
- Acute Myeloid Leukemia Research 241
- Chronic Myeloid Leukemia Treatments 158
- Multiple Myeloma Research and Treatments 116
- Oncology 318
- CAR-T cell therapy research 95
- Co-authors
- Sergio Giralt (247 shared papers)Issa F. Khouri (206 shared papers)Börje S. Andersson (189 shared papers)Paolo Anderlini (136 shared papers)Robert Peter Gale (46 shared papers)Elizabeth J. Shpall (251 shared papers)Marcos de Lima (165 shared papers)Gabriela Rondón (217 shared papers)
- Journals
- Blood (316 papers)Biology of Blood and Marrow Transplantation (180 papers)Journal of Clinical Oncology (70 papers)Bone Marrow Transplantation (61 papers)Cancer (33 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Richard E. Champlin
1.1k papers receiving 46.1k citations
Richard E. Champlin's Hit Papers
Peers
Comparison fields: 5 of 167
- Hematology 27.0k
- Genetics 7.9k
- Transplantation 1.7k
- Immunology 11.8k
- Oncology 13.8k
Countries citing papers authored by Richard E. Champlin
This map shows the geographic impact of Richard E. Champlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard E. Champlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard E. Champlin more than expected).
Fields of papers citing papers by Richard E. Champlin
This network shows the impact of papers produced by Richard E. Champlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard E. Champlin. The network helps show where Richard E. Champlin may publish in the future.
Co-authors
The 25 scholars most cited alongside Richard E. Champlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 1.1k papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. Hit paper breakdown → | 1997 | 1042 |
| 2 | Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy Hit paper breakdown → | 1997 | 942 |
| 3 | Outcomes after Transplantation of Cord Blood or Bone Marrow from Unrelated Donors in Adults with Leukemia Hit paper breakdown → | 2004 | 833 |
| 4 | Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Hit paper breakdown → | 2002 | 801 |
| 5 | Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. Hit paper breakdown → | 1998 | 766 |
| 6 | Hepatocytes and Epithelial Cells of Donor Origin in Recipients of Peripheral-Blood Stem Cells Hit paper breakdown → | 2002 | 644 |
| 7 | Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Hit paper breakdown → | 1988 | 627 |
| 8 | Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study Hit paper breakdown → | 2007 | 598 |
| 9 | Zygomycosis in a Tertiary‐Care Cancer Center in the Era of Aspergillus‐ Active Antifungal Therapy: A Case‐Control Observational Study of 27 Recent Cases Hit paper breakdown → | 2005 | 562 |
| 10 | Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia Hit paper breakdown → | 2000 | 548 |
| 11 | Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells Hit paper breakdown → | 2012 | 517 |
| 12 | 2001 | 463 | |
| 13 | 2001 | 447 | |
| 14 | 2012 | 441 | |
| 15 | 2010 | 419 | |
| 16 | 2000 | 419 | |
| 17 | 2016 | 362 | |
| 18 | 2015 | 339 | |
| 19 | 2010 | 336 | |
| 20 | 2004 | 327 |
About Richard E. Champlin
Richard E. Champlin is a scholar working on Hematology, Oncology, Genetics, Immunology and Public Health, Environmental and Occupational Health, having authored 1.1k papers that have together received 48.0k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (468 papers), Acute Myeloid Leukemia Research (241 papers), Chronic Myeloid Leukemia Treatments (158 papers), Acute Lymphoblastic Leukemia research (154 papers), Chronic Lymphocytic Leukemia Research (127 papers), Multiple Myeloma Research and Treatments (116 papers), Immune Cell Function and Interaction (110 papers) and CAR-T cell therapy research (95 papers). The work is most often cited by research in Hematology (27.0k citations), Genetics (7.9k citations), Transplantation (1.7k citations), Immunology (11.8k citations) and Oncology (13.8k citations). Richard E. Champlin has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Sergio Giralt, Issa F. Khouri, Börje S. Andersson, Paolo Anderlini, Robert Peter Gale, Elizabeth J. Shpall, Marcos de Lima, Gabriela Rondón, Chitra Hosing and Hagop M. Kantarjian. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Journal of Clinical Oncology, Bone Marrow Transplantation and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.